HOMOLOGY MEDICINES INC (FIXX) Earnings History & Surprises

NASDAQ:FIXXUS4380831077

Current stock price

0.9347 USD
+0.01 (+0.77%)
At close:
0.892 USD
-0.04 (-4.57%)
After Hours:

FIXX Earnings overview

Past quarterly earnings results for HOMOLOGY MEDICINES INC (FIXX), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release Date
May 9, 2024
Period
Q1 / 2024
EPS Estimate
-$0.23
Revenue Estimate

Last Reported

Most Recent
Release Date
Mar 13, 2024
Period
Q4 / 2023
EPS Reported
-$0.28
EPS Surprise
8.50%
Revenue Surprise
%

Beat Rate

Last 8 Quarters
25%
EPS and Revenue beats vs estimates

Quarterly Earnings Historical Results

EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q4 2023 -0.28 -0.31 8.50% 53.33% - -100.00%
Q3 2023 -0.57 -0.43 -33.05% 3.39% 510K -100.00% -100.00%
Q2 2023 -0.61 -0.48 -25.90% -19.61% 350K 858.157K -59.21% -56.25%
Q1 2023 -0.50 -0.54 7.51% -150.00% 800K 1.035M -22.71% -
Q4 2022 -0.60 -0.51 -16.77% -1.69% 800K 847.008K -5.55% -
Q3 2022 -0.59 -0.48 -22.42% -9.26% 800K 877.608K -8.84% -52.38%
Q2 2022 -0.51 -0.57 9.97% 5.56% 800K 1.021M -21.65% -63.47%
Q1 2022 -0.20 -0.36 43.98% -900.00% 800K 21.106M -96.21% -97.27%
Q4 2021 -0.59 -0.60 2.33% 4.84% 800K 756.728K 5.72% -18.37%
Q3 2021 -0.54 -0.61 11.72% 12.90% 1.68M 701.25K 139.57% 194.74%
Q2 2021 -0.54 -0.60 10.57% 30.77% 2.19M 438.294K 399.66% 284.21%
Q1 2021 -0.02 -0.68 97.07% 97.44% 29.31M 527.595K 5,455.40% 4,867.80%
Q4 2020 -0.62 -0.69 10.02% - 980K 1.148M -14.63% -
Q3 2020 -0.62 -0.82 24.42% - 570K 491.64K 15.94% -
Q2 2020 -0.78 -0.78 -0.33% - 570K 525.637K 8.44% -
Q1 2020 -0.78 -0.69 -12.29% - 590K 581.4K 1.48% -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

FIXX EPS Q2Q GrowthFIXX EPS Q2Q GrowthEPS Q2Q Growth Q1/21 Q2/21 Q3/21 Q4/21 Q1/22 Q2/22 Q3/22 Q4/22 Q1/23 Q2/23 Q3/23 Q4/23 Q1/24 Q2/24 Q3/24 Q4/24 0 -200 -400 -600 -800

Revenue Historical Q2Q growth and Acceleration

FIXX Revenue Q2Q GrowthFIXX Revenue Q2Q GrowthRevenue Q2Q Growth Q1/21 Q2/21 Q3/21 Q4/21 Q1/22 Q2/22 Q3/22 Q4/22 Q1/23 Q2/23 Q3/23 Q4/23 Q1/24 Q2/24 0 1K 2K 3K 4K

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
2
Average EPS beat (4)
-10.74%
Max EPS beat (4)
8.50%
Min EPS beat (4)
-33.05%

Revenue beat statistics

Revenue beat (4)
N/A
Average Revenue beat (4)
N/A
Max Revenue beat (4)
N/A
Min Revenue beat (4)
N/A

Analysis

In the last 4 quarters, FIXX has beaten EPS estimates in 2 out of 4 releases
In the last 4 quarters, FIXX reported -10.7% below the EPS estimates on average.

HOMOLOGY MEDICINES INC / FIXX Earnings FAQ

What is the most recent earnings date for FIXX stock?

HOMOLOGY MEDICINES INC (FIXX) last reported earnings on 3/13/2024.

Did HOMOLOGY MEDICINES INC (FIXX) beat earnings estimates last quarter?

HOMOLOGY MEDICINES INC (FIXX) beat EPS estimates and missed revenue estimates in the most recent quarter.

Can you provide information on how often HOMOLOGY MEDICINES INC beats earnings estimates?

In the last 4 quarters, HOMOLOGY MEDICINES INC (FIXX) has beaten EPS estimates in 2 out of 4 releases.